Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma

Serum Mesothelin for Diagnosing Malignant Pleural Mesothelioma: An Individual Patient Data Meta-Analysis

(2012) Kevin Hollevoet et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular Pathways: Targeting Mechanisms of Asbestos and Erionite Carcinogenesis in Mesothelioma

(2011) M. Carbone et al.   CLINICAL CANCER RESEARCH

Malignant mesothelioma: Facts, Myths, and Hypotheses

(2011) Michele Carbone et al.   JOURNAL OF CELLULAR PHYSIOLOGY

High-mobility group box 1 and cancer

(2010) Daolin Tang et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

High-Mobility Group Box 1–Mediated Matrix Metalloproteinase-9 Expression in Non–Small Cell Lung Cancer Contributes to Tumor Cell Invasiveness

(2009) Po-Len Liu et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Occupational, domestic and environmental mesothelioma risks in the British population: a case–control study

(2009) C Rake et al.   BRITISH JOURNAL OF CANCER

Potential Role of High-Mobility Group Box 1 in Cystic Fibrosis Airway Disease

(2008) Steven M. Rowe et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The Role of High Mobility Group Box1 in Pulmonary Fibrosis

(2008) Naoki Hamada et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Modulated Inflammation by Injection of High-Mobility Group Box 1 Recovers Post-Infarction Chronically Failing Heart

(2008) K. Takahashi et al.   CIRCULATION